Human factors engineering for FDA medical-device submissions

Service · Human Factors Engineering

Use-related risk analysis grounded in the ISO 14971 hazard analysis, formative usability evaluation, and summative human-factors validation testing, ending in the eight-section package FDA's 2016 human-factors guidance describes, ready to attach to a 510(k), PMA, or De Novo submission.

What does human factors engineering deliver for an FDA submission?

It delivers use-related risk analysis grounded in the ISO 14971 hazard analysis, formative usability evaluation, and summative human-factors validation testing. The result is the eight-section package FDA's 2016 human-factors guidance describes, ready for a 510(k), PMA, or De Novo submission.

Use-related risk analysis, formative usability evaluation, and summative human-factors validation testing, ending in the eight-section submission package FDA's 2016 human-factors guidance describes — built to reduce use-related risk before submission, not to explain it away after an FDA reviewer flags it.

From critical-task identification to a submission-ready package

FDA's 2016 guidance, Applying Human Factors and Usability Engineering to Medical Devices (Docket FDA-2011-D-0469), expects a specific evidence chain: identify critical tasks and use-related hazards, evaluate the interface formatively and iterate the design against what that evaluation finds, then validate summatively that a representative user population can perform the critical tasks safely.

Critical Task Focus: Use-related hazards and critical tasks identified before a single screen is designed.
Formative Iteration: The interface evaluated and revised against what formative testing actually finds.
Summative Validation: A representative user population tested performing the critical tasks under real conditions.
FDA Submission Ready: Deliverables structured to FDA's own eight-section guidance, not reformatted after the fact.

ARCH-SPEC 01: Human Factors Validation Architecture

IEC 62366 FDA HF GUIDANCE DETERMINISTIC VERIFICATION

Six capability areas

Use-Related Risk Analysis (URRA)

Critical tasks and use-related hazards identified before design work begins, grounded in ISO 14971's risk-analysis process.

Critical Task Identification
Known Use-Problem Analysis
Use-Related Hazard Analysis

User Profile & Environment Definition

Intended users, use environments, and device interface description with design rationale, documented to the guidance's own structure.

Intended User Population
Use Environment Definition
Device Interface Description

Formative Usability Testing

Iterative evaluation of the interface against candidate designs, feeding each finding back into the next revision.

Preliminary Evaluation Rounds
Design Iteration Tracking
Evaluation Summary Reports

Summative Validation Protocols

A representative user population tested performing the critical tasks under conditions that mirror actual use.

Validation Test Protocol Design
Representative Participant Recruiting
Critical Task Success Criteria

Interface Risk Mitigations

Design changes that measurably reduce use-related risk, traced back to the specific hazard each one closes.

Hazard-to-Mitigation Traceability
Residual Risk Assessment
Design Rationale Documentation

8-Section FDA Submission Package

The complete MedTech deliverable is structured to FDA's own eight sections, ready to attach to a 510(k), PMA, or De Novo submission.

Eight-Section Report Assembly
Validation Testing Results
Reviewer-Ready Formatting

This service pairs with the underlying standard reference — see IEC 62366 Human Factors & Usability Engineering for Medical Software for what the governing standard itself requires, independent of any specific engagement.

Three documentation levels, set by what the device change touches

The amount of human-factors evidence a submission needs depends on whether the device's use-related hazards and critical tasks are affected. We help you determine which level applies before any testing is scoped.

Category 1

Minimal documentation

Changes do not affect use-related hazards, so limited human-factors information is needed.

No new use errors introduced
No change to the user interface
Similar to the predicate device

Category 2

Moderate documentation

Changes affect hazards but do not add or alter critical tasks.

Modified user interface
No critical tasks affected
Formative testing may suffice

Category 3

Full human-factors validation

The device has critical tasks, or the change touches them.

Critical tasks present
Summative validation testing required
Complete human-factors submission package

SOC 2 TYPE 1 & 2 CERTIFIED IEC 62366 FDA HF GUIDANCE

Ready to Build?

Discuss a human factors study or FDA submission package for a specific device.

Start a Conversation → Schedule Engineering Call

Engineering reference only. Not formal regulatory counsel. Consult your own quality system and legal counsel for a specific regulatory determination.